Topic: Life Sciences & Medicine
-
-
-
-
News
Lessons learnt: Luxembourg’s COVID-19 management as a blueprint for pandemic preparedness
Learn more -
News
International research on healthy aging, senescence and neurodegeneration at the Venusberg conference
Learn more -
-
News
A public-private partnership to assess a novel drug candidate for Parkinson’s disease
Learn moreACT-02 is a novel compound with disease-modifying potential. It inhibits the enzyme Prolyl Endopeptidase (PREP), a promising but previously overlooked target in Parkinson’s disease. This drug candidate has demonstrated properties to improve cognition while reducing motor symptoms, neuroinflammation and alpha-synuclein aggregation in preclinical models of brain disorders. The ACT-02 program is currently at an advanced…
-
News
Rotary Club Esch-Bassin Minier supports LCSB research
Learn moreProf. Wilmes received a donation by the Rotary Club Esch-Bassin Minier.
-
News
Venturing into the brand-new field of biocomputing and organoid intelligence
Learn moreResearchers at the LCSB are modelling the complexity of the human brain in a dish. Their work is highlighted in the latest episode of Primer, a new global series from Bloomberg Originals that breaks down the complex science, technologies and industries shaping the future. Aired on 27 March, this episode is titled “Can Living Human…
-
News
Forever chemicals, diving into troubled waters
Learn moreOn World Water Day, let’s talk about the “forever chemicals” that made a splash when the Forever Pollution Project published the map of nearly 23,000 contaminated sites all over Europe and again when the Pesticide Action Network Europe revealed that drinking water samples from 11 EU countries showed the widespread presence of trifluoroacetic acid (TFA).…